{"text": ["Biogen", "SMA", "drug", "price,", "Novartis", "estimates", "for", "its", "treatment", "far", "too", "high:", "U.S.", "group"], "created_at": "2019-04-03 22:08:33"}
{"text": ["Biogen", "SMA", "drug", "price,", "Novartis", "estimates", "for", "its", "treatment", "far", "too", "high", "-U.S.", "group"], "created_at": "2019-04-03 21:41:05"}
{"text": ["Biogen", "SMA", "drug", "price,", "Novartis", "estimates", "for", "its", "treatment", "far", "too", "high", "-U.S.", "group"], "created_at": "2019-04-03 20:37:23"}
{"text": ["Roche", "Extends", "Offer", "Period", "for", "Spark", "Therapeutics", "Acquisition"], "created_at": "2019-04-03 16:06:54"}
{"text": ["Roche", "Extends", "Offer", "Period", "for", "Spark", "Therapeutics", "Acquisition"], "created_at": "2019-04-03 16:06:54"}
{"text": ["Allergan's", "AMD", "Drug", "Lowers", "Inflammation", "in", "Phase", "III", "Study"], "created_at": "2019-04-03 16:06:22"}
{"text": ["Allergan's", "AMD", "Drug", "Lowers", "Inflammation", "in", "Phase", "III", "Study"], "created_at": "2019-04-03 16:06:22"}
{"text": ["After", "inking", "lease", "with", "cancer-fighting", "company,", "this", "new", "East", "Bay", "biotech", "project", "is", "full"], "created_at": "2019-04-03 14:02:41"}
{"text": ["Allergan's", "AMD", "Drug", "Lowers", "Inflammation", "in", "Phase", "III", "Study"], "created_at": "2019-04-03 14:00:02"}
{"text": ["Roche", "Extends", "Offer", "Period", "for", "Spark", "Therapeutics", "Acquisition"], "created_at": "2019-04-03 13:49:01"}
{"text": ["The", "Daily", "Biotech", "Pulse:", "Advaxis", "Offering,", "Roche's", "Spark", "Tender", "Offer", "Extended,", "Ascendis", "Earnings"], "created_at": "2019-04-03 12:19:01"}
{"text": ["Novartis's", "Alcon", "spinoff", "ousts", "Baer", "from", "Swiss", "benchmark", "SMI"], "created_at": "2019-04-03 09:51:42"}
